Quoin Pharmaceuticals, Ltd.QNRXNASDAQ
Loading
SG&A Expense Growth Under PressureDecelerating
Percentile Rank38
Year-over-Year Change
Year-over-year SG&A expense growth
Latest
-0.22%
↓ 103% vs avg
Percentile
P38
Within normal range
Streak
2 qtr
Consecutive declineDecelerating
Average
8.80%
Historical baseline
| Period | Value |
|---|---|
| Q3 2025 | -0.22% |
| Q2 2025 | 10.08% |
| Q1 2025 | 18.59% |
| Q4 2024 | -1.68% |
| Q3 2024 | -12.38% |
| Q2 2024 | -1.49% |
| Q1 2024 | 13.55% |
| Q4 2023 | 1.38% |
| Q3 2023 | -16.42% |
| Q2 2023 | -2.90% |
| Q1 2023 | 14.32% |
| Q4 2022 | -6.90% |
| Q3 2022 | -18.51% |
| Q2 2022 | 22.22% |
| Q1 2022 | -19.55% |
| Q4 2021 | 89.35% |
| Q3 2021 | 41.37% |
| Q2 2021 | -0.99% |
| Q1 2021 | 56.27% |
| Q4 2020 | 57.79% |
| Q3 2020 | -6.81% |
| Q2 2020 | 0.42% |
| Q1 2020 | 0.00% |
| Q4 2019 | 0.00% |
| Q4 2018 | 0.00% |
| Q4 2017 | 0.00% |
| Q4 2016 | 0.00% |